Skip to main content

Banner that says "Help Support UNC Researchers Fight Against COVID-19" Click to donate.

  • Lasting Protection from COVID-19

    Vaccination offers long-lasting protection from the worst outcomes of COVID-19, according to a new study from the UNC Gillings School of Global Public Health.

  • Illustration of split pill with red spheres spilling out of it

    COVID-19 Antiviral Pill Approved

    The FDA has approved antiviral pills you take once you’ve been infected to fight COVID-19. Learn more about the pills and how UNC researchers helped with testing the safety and efficacy of molnupiravir, developed by Ridgeback Biotherapeutics and Merck

  • GlycoGrip SARS-CoV-2 rapid test

    Low-Cost Test Strip Could Be Game-Changer

    Researchers from UNC and the University of California, San Diego have developed a low-cost test strip that provides a simple and accurate detection of COVID-19 infection within minutes. Its portability and ease of manufacture could make it globally available, especially in rural or low-income areas that typically lack easy access to expensive PCR testing equipment.

  • Chart of what NC residents think are biggest concerns in the face of COVID

    Gauging Statewide COVID Impact

    Carolina Across 100, an initiative in all NC counties, finished data analysis of surveys and found that people across the state are concerned about employment stability, education and the presence of small businesses as the COVID-19 pandemic continues.

  • Gloved person arranging boxes of the Johnson & Johnson vaccine

    Possible Benefits to J&J Vaccine

    “I think there is a silver lining to [the J&J] vaccine that a lot of people don’t see,” says David Martinez, a UNC Gillings School of Public Health postdoctoral fellow. He researches immune responses to COVID-19 vaccines. Several researchers report early hints that, while J&J offers less protection up front, it may remain effective in the body for much longer.

  • READDI Awarded Grant to Prepare For Next Pandemic

    A group of nine researchers led by UNC-Chapel Hill from the Rapidly Emerging Antiviral Drug Development Initiative (READDI) is the winner of the institute’s Forethought Research Collaboration Challenge, securing them with $5 million to help accelerate the production of antiviral drugs in the future.

Earlier stories…

Rachel Woodul

A Public Health Prognosis

Graduate student Rachel Woodul spent three years researching what might happen to hospital capacity when the next pandemic strikes. When it arrived, she compared what her model — and others’ — got wrong to improve how we react to public health crises in the future.

Cynthia Smudde

In It for the Long Haul

For some COVID-19 patients, the initial infection is just the start of the battle. Post-COVID syndrome occurs when a person’s symptoms continue long after their infection ends. A new clinic at UNC hopes to not only help these patients, but also provide researchers with valuable data about this strange syndrome.

Suzanne Zaccardo holds an American flag and says the pledge of allegiance to her computer for her online class of first graders

Learning As We Go

While the controversy surrounding when and how schools should reopen has led to policy debates and changes in family dynamics, UNC epidemiologists and education researchers find hope in the lessons from this year.